A composition including a fluorine-containing polymer and a silicon-containing compound, wherein the phosphorus content in the composition is 20 ppm or less. Also disclosed is a molded article obtained from the composition, and a second composition containing a fluorine-containing polymer and a silicon-containing polymer, wherein a content of an amide solvent in the composition is less than 1000 ppm.

A modified polyamide is provided, which has a structure of formula (1), in which a+c is 3-8, b is 8-40, m is 3-11, n is 2-16, x is 100-220, and y is 1-6. A method of preparing a modified polyamide is also provided, which includes copolymerizing C4-C12 lactam, C4-C18 linear aliphatic dicarboxylic acid, polyetherdiamine, and diethylenetriamine (DETA), in which the lactam is 80 to 95 parts by weight, and the linear aliphatic dicarboxylic acid is 1 to 4 parts by weight, and the polyetherdiamine is 4 to 16 parts by weight, and the diethylenetriamine is 0.2 to 0.6 parts by weight.

A modified polyamide is provided, which has a structure of formula (1), in which a+c is 3-8, b is 8-40, m is 3-11, n is 2-16, x is 100-220, and y is 1-6. A method of preparing a modified polyamide is also provided, which includes copolymerizing C4-C12 lactam, C4-C18 linear aliphatic dicarboxylic acid, polyetherdiamine, and diethylenetriamine (DETA), in which the lactam is 80 to 95 parts by weight, and the linear aliphatic dicarboxylic acid is 1 to 4 parts by weight, and the polyetherdiamine is 4 to 16 parts by weight, and the diethylenetriamine is 0.2 to 0.6 parts by weight.

The invention relates to a non-cross-linked copolymer foam with polyamide blocks and polyether blocks, wherein: the polyamide blocks of the copolymer have an average molar mass of from 200 to 1,500 g/mol; the polyether blocks of the copolymer have an average molar mass of from 800 to 2,500 g/mol; and the weight ratio of the polyamide blocks to the polyether blocks of the copolymer is from 0.1 to 0.9. The invention also relates to a method for manufacturing said foam and items manufactured from said foam.

The invention relates to a non-cross-linked copolymer foam with polyamide blocks and polyether blocks, wherein: the polyamide blocks of the copolymer have an average molar mass of from 200 to 1,500 g/mol; the polyether blocks of the copolymer have an average molar mass of from 800 to 2,500 g/mol; and the weight ratio of the polyamide blocks to the polyether blocks of the copolymer is from 0.1 to 0.9. The invention also relates to a method for manufacturing said foam and items manufactured from said foam.

The invention relates to a composition comprising: (A) an amorphous or quasi-amorphous copolymer containing polyamide blocks and containing polyether blocks, the polyamide blocks comprising cycloaliphatic units; (B) a semicrystalline polymer or copolymer comprising amide units; (C) another polymer or copolymer comprising amide units; and (D) a multilayer polymer comprising at least a layer (D1) and a layer (D2). This composition has advantageous properties of transparency and impact strength, especially for the manufacture of sports articles.

The invention relates to a composition comprising: (A) an amorphous or quasi-amorphous copolymer containing polyamide blocks and containing polyether blocks, the polyamide blocks comprising cycloaliphatic units; (B) a semicrystalline polymer or copolymer comprising amide units; (C) another polymer or copolymer comprising amide units; and (D) a multilayer polymer comprising at least a layer (D1) and a layer (D2). This composition has advantageous properties of transparency and impact strength, especially for the manufacture of sports articles.

The present disclosure is directed to nanoparticle delivery systems for delivering biological agents, pharmaceutical compositions of comprising these nanoparticles, and methods of using these compositions. Certain embodiments of the present disclosure provide nanoparticles comprising polymers comprising alternating charged and uncharged segments comprising one or more of the following structural units of Formula (I) Formula (III):

##STR00001##

wherein A is an uncharged segment comprising polyalkylene glycol; and B is a cationically charged segment comprising at least one polyhydroxy linkage.

The present disclosure is directed to nanoparticle delivery systems for delivering biological agents, pharmaceutical compositions of comprising these nanoparticles, and methods of using these compositions. Certain embodiments of the present disclosure provide nanoparticles comprising polymers comprising alternating charged and uncharged segments comprising one or more of the following structural units of Formula (I) Formula (III):

##STR00001##

wherein A is an uncharged segment comprising polyalkylene glycol; and B is a cationically charged segment comprising at least one polyhydroxy linkage.

A polyamide resin with an excellent balance of mechanical characteristics such as breaking strength and breaking elongation in a solid state, a molded body containing said polyamide resin, a laminate provided with a film or a sheet containing said polyamide resin, a medical device provided with the aforementioned molded body and/or the aforementioned laminate, and a production method of the aforementioned polyamide resin are provided. A polyamide resin is used which contains: a linear aliphatic dicarbonyl unit as unit (a); a linear aliphatic diamino unit as unit (b); at least one of a unit (b) and a unit (c), each of a prescribed structure; and a trivalent unit (e).